is head of Milbank’s IP litigation and licensing group. His practice focuses on IP litigation and licensing, with an emphasis on complex patent litigation. David is nationally recognised for his expertise in life sciences matters. His work spans a broad array of industries and technologies, and he has achieved extraordinary trial outcomes for both plaintiffs and defendants, including a USD302 million verdict for breach of a research and licence agreement, as well as defeating a USD217 million damages claim where liability had already been established in an earlier trial handled by a different law firm.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.